Skip to content
BT30BT30BT30

Drawing based on the label description. No photo yet.

“Tablets: 30 mg of brepocitinib; pink, capsule-shaped, immediate-release, film-coated, and debossed with "BT30" on one side”

BT30 pill

Pill with imprint BT30 is pink, capsule, 12 mm and has been identified as Brepocitinib 30 mg. It is supplied by Priovant Therapeutics, Inc.

Brepocitinib 30 mg

Imprint
BT30
Strength
30 mg
Color
Pink
Shape
Capsule / oblong
Size
12 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Priovant Therapeutics, Inc
NDC
87211-030, 87211-030-30

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Brepocitinib pills and guides

What is Brepocitinib used for?

Official uses from the US prescribing label

LISRAYA is indicated for the treatment of dermatomyositis in adult patients.

Limitations of Use

LISRAYA is not recommended for use in combination with other JAK inhibitors, other TYK2 inhibitors, or biologic DMARDs.

From the FDA-approved label on DailyMed (published Sep 02, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows BT30 and the other side has no imprint.
  • It is pink, capsule, 12 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Lisraya.

Ingredients

Active: Brepocitinib Tosylate

Inactive: Hypromellose 2910 (6 Mpa.s), Ferric Oxide Red, Lactose Monohydrate, Magnesium Stearate, Microcrystalline Cellulose, Sodium Starch Glycolate Type A, Titanium Dioxide, Triacetin

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.